Does Allopurinol Make You Pee More?

Allopurinol is not a diuretic and does not directly increase how often or how much you urinate. It works by lowering uric acid production in your body, which is a completely different job from making the kidneys push out more fluid. But the question comes up often enough to deserve a real explanation, because allopurinol does interact with kidney function in ways that can feel confusing, and many people taking it also happen to be on actual diuretics for other conditions.

What Allopurinol Actually Does

Allopurinol targets an enzyme called xanthine oxidase, which is responsible for converting certain compounds into uric acid. By blocking that enzyme, allopurinol reduces the amount of uric acid your body produces in the first place. In animal studies, even a relatively low dose significantly decreased circulating uric acid levels within an hour while increasing levels of hypoxanthine, one of the precursor molecules that would normally be converted into uric acid.1PubMed Central. Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase The drug itself is quickly metabolized into oxypurinol, which continues doing the same job for much longer in the bloodstream.

None of this has anything to do with how your kidneys handle water. Diuretics work by changing how the kidneys reabsorb sodium, which pulls water along with it and increases urine volume. Allopurinol does not touch that process. If you started allopurinol and noticed you were urinating more, the explanation almost certainly lies somewhere else: a change in fluid intake, a different medication added around the same time, or even just paying closer attention to your body because you started a new drug.

Why So Many Gout Patients Are Also on Diuretics

Part of the confusion stems from the fact that the people who take allopurinol tend to share a medical profile with people who take diuretics. Gout, the condition allopurinol most commonly treats, clusters with high blood pressure, heart failure, and kidney problems. Diuretics like hydrochlorothiazide are among the most widely prescribed blood pressure medications, and they are notorious for raising uric acid levels, which can trigger or worsen gout. So you end up with a situation where a patient is taking a diuretic (which does make you pee more and raises uric acid) alongside allopurinol (which lowers uric acid). It is easy to mentally merge the two drugs’ effects.

Researchers have looked at whether diuretics interfere with how well allopurinol works. One study of gout patients found a weak initial signal suggesting that diuretic use correlated with lower maximum allopurinol doses, but the association disappeared entirely after accounting for other factors like age and kidney function.2PubMed Central. Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort A separate study looking specifically at the interaction between allopurinol and hydrochlorothiazide found that the diuretic did not meaningfully alter blood levels of oxypurinol, allopurinol’s active metabolite, and concluded that the pharmacokinetic interaction did not explain why uric acid tends to creep up when someone is on a thiazide diuretic.3PubMed. Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. II. Kinetics of allopurinol, oxipurinol, and hydrochlorothiazide In other words, if you are on both medications, the diuretic is the reason you are peeing more, and the two drugs do not significantly change each other’s behavior in the body.

Allopurinol and Kidney Function

While allopurinol does not make you urinate more, it does affect the kidneys in subtler ways. Uric acid itself can damage kidney tissue over time, so lowering it with allopurinol has long been hoped to protect kidney function. The evidence here is genuinely mixed, and the story has shifted over the past decade.

An earlier trial of patients with chronic kidney disease found encouraging results: after two years, patients on allopurinol saw their estimated kidney filtration rate improve slightly, while the control group’s filtration rate declined. The allopurinol group also showed slower overall disease progression, independent of factors like age, diabetes, or blood pressure medication use.4PubMed Central. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk A separate analysis found that allopurinol-treated patients achieved roughly 12 mL/min higher filtration rates than controls, with the benefit appearing larger in patients who started with better kidney function.5PubMed. The Effect of Allopurinol on Renal Function

But then a much larger, placebo-controlled trial threw cold water on the idea. In patients with chronic kidney disease at high risk of progression, allopurinol did not slow the decline in kidney filtration compared to placebo at all. The yearly rate of filtration loss was essentially identical in both groups.6PubMed. Effects of Allopurinol on the Progression of Chronic Kidney Disease This trial was bigger and better designed than the earlier ones, and it shifted the expert consensus toward skepticism about allopurinol as a kidney-protective drug in general chronic kidney disease. The earlier positive results may have reflected smaller sample sizes or differences in patient populations rather than a real treatment effect.

For the person wondering about urination, the practical takeaway is that allopurinol is not boosting your kidneys’ ability to filter and excrete fluid in a way you would notice at the toilet. Even in the studies where filtration rates modestly improved, the changes were small enough that they would not translate into perceptible differences in urine output.

The Urine Protein Connection

One place where allopurinol does appear to change what shows up in urine is protein levels. In patients with diabetes and early kidney damage, allopurinol has been associated with reduced protein in the urine, which is a marker of kidney health rather than something you would notice day to day. A meta-analysis of diabetic patients found significantly lower 24-hour urine protein in the allopurinol group compared to controls.7PubMed Central. Effects of allopurinol on renal function in patients with diabetes: a systematic review and meta-analysis A smaller clinical trial in patients with diabetic kidney disease confirmed this pattern: after six months, uric acid and urinary protein both dropped significantly in the allopurinol group but not in the control group.8Journal of Renal Injury Prevention. Effect of allopurinol on diabetic nephropathy; a double-blind clinical trial study

Less protein in the urine is a good sign for the kidneys. But it has nothing to do with peeing more or less. You would only know about this change if your doctor ran a urine lab test. The composition of your urine is shifting slightly, not the volume.

Could Increased Water Intake Be the Real Culprit?

When doctors prescribe allopurinol, they routinely advise patients to drink more water. The reasoning is straightforward: as uric acid levels drop, the balance of waste products being filtered through the kidneys shifts. Higher fluid intake helps flush these substances through the urinary tract and reduces the risk of kidney stones. Some patients follow this advice enthusiastically, especially if they have a history of gout flares or kidney stones, and suddenly find themselves making more trips to the bathroom. It is tempting to blame the pill, but it is really the extra water doing the work.

Adequate hydration is standard advice for anyone with gout regardless of medication, since concentrated urine is a risk factor for uric acid stones. If you started allopurinol around the same time you started taking hydration more seriously, the timing overlap could easily create the impression that the drug itself is a diuretic.

Allopurinol’s Effect on Blood Pressure

Another indirect connection worth understanding is allopurinol’s relationship with blood pressure. A meta-analysis found that allopurinol use was associated with a modest drop in systolic blood pressure of about 3 mm Hg and a diastolic drop of about 1 mm Hg.9PubMed Central. Effect of allopurinol on blood pressure: a systematic review and meta-analysis The effect is small but statistically real across the studies analyzed. However, individual trials tell a more nuanced story. A crossover trial in young adults with elevated uric acid found no significant blood pressure change with allopurinol, though it did find improved blood vessel function as measured by how well arteries relaxed.10PubMed. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial Another trial in hypertensive patients found no blood pressure changes from adding allopurinol, but did observe improved arterial stiffness.11PubMed. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients

Why does this matter for the urination question? Because if allopurinol slightly reduces blood pressure in some patients, it could marginally change how the kidneys handle fluid. Lower blood pressure generally means slightly less filtration pressure at the kidneys, which would if anything mildly reduce urine production, not increase it. The vascular effects are interesting on their own terms, but they do not point toward peeing more.

How Febuxostat Compares

Febuxostat is the other major xanthine oxidase inhibitor available, and people sometimes switch between the two drugs. If you switched from allopurinol to febuxostat (or vice versa) and noticed a change in urination, the drugs themselves are unlikely to be the explanation. In head-to-head comparisons, febuxostat lowered uric acid somewhat more effectively, but the two drugs performed similarly on kidney filtration measures. A meta-analysis found that febuxostat produced a greater reduction in albuminuria (protein leaking into urine) and a slightly larger uric acid drop compared to allopurinol, but there was no significant difference in creatinine levels or sustained kidney filtration differences beyond the first month.12PubMed Central. Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis A later study of patients with chronic kidney disease confirmed that there were no significant differences in filtration rate changes over time between the two drugs.13Scientific Reports. Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease

A network meta-analysis focused on patients with more advanced kidney disease did find that febuxostat might have a slight edge in preserving kidney filtration, though the confidence interval was wide enough to include no real difference.14PubMed Central. Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3–5 patients with asymptomatic hyperuricemia: a network meta-analysis Neither drug is designed or expected to change how much you urinate in any noticeable way.

Side Effects That Could Mimic Urinary Changes

Allopurinol does have real side effects, and a few of them could create the subjective impression that your urinary habits have changed. Gastrointestinal symptoms like nausea and diarrhea are among the more common complaints. Diarrhea in particular can shift your fluid balance, potentially making you feel like you are losing more fluid than usual or making you drink more to compensate, which in turn leads to more urination. Skin rashes are the side effect that gets the most clinical attention, and in rare cases allopurinol can trigger a severe hypersensitivity reaction that affects multiple organs including the kidneys. These serious reactions are uncommon, but they can cause dramatic changes in kidney function and urine output. If you experience a rash alongside changes in how much or how little you are peeing, that combination warrants immediate medical attention.

Gout flares themselves are another confounding factor. Starting allopurinol can temporarily trigger flares as uric acid crystals shift around in the joints. During a flare, inflammation surges, and some people instinctively drink more fluids or take anti-inflammatory medications that have their own effects on kidney function. The overall picture is one where many things change at once when someone begins gout treatment, and pinning a change in urination specifically on allopurinol requires ruling out all of these other moving parts.

When to Actually Worry About Urinary Changes on Allopurinol

Most of the time, peeing more or less on allopurinol is not a sign that anything is wrong. But there are a few scenarios where changes in urination while taking the drug should prompt a conversation with your doctor:

  • Dramatic decrease in urine output: This could signal a kidney problem, especially if it comes alongside swelling in the legs, fatigue, or difficulty breathing.
  • Dark or tea-colored urine with a new rash: Allopurinol hypersensitivity syndrome can involve the kidneys, and changes in urine color along with skin symptoms are a red flag.
  • Pain during urination or visible stones: While rare, xanthine stones can form in patients on allopurinol because the drug shifts the breakdown of purines away from uric acid and toward xanthine. If xanthine concentrations get high enough, particularly in patients producing large amounts of uric acid to begin with, these unusual stones can develop.
  • New medication added recently: If a diuretic was started at the same time as allopurinol, the diuretic is almost certainly the cause of increased urination.

For the vast majority of people taking allopurinol for gout or elevated uric acid, the drug will quietly lower uric acid levels in the background without any noticeable effect on how often you visit the bathroom. The urination question usually resolves once people identify the real cause, whether that is a co-prescribed diuretic, increased water intake on their doctor’s advice, or simply the heightened body awareness that comes with starting any new medication.

Francesca Lindsay

Francesca Lindsay has spent 16 years as a clinical pharmacist in internal medicine at an academic medical center. She earned her PharmD at the UNC Eshelman School of Pharmacy, completed a PGY-1 residency and is a Board Certified Pharmacotherapy Specialist. Her clinical focus is dosing and adverse drug reactions in complex patients.